Sign inJoin waitlistJoin the waitlist

AS

Alexandra Sokolova

Assistant Leader, Translational Oncology Program · Oregon Health & Science University

Credentials: · · · · · ·

History

Translational Oncology Program · Oregon Health & Science University
Present
GU Malignancies Genomics · Oregon Health & Science University
Present
Oregon Health & Science University
Present

Hematology and Medical Oncology
University of Washington-Seattle Campus
2014–2017
Internal Medicine
Nassau University Medical Center
2011–2014
Rostov State Medical University
2009–2013

Research

Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference
JAMA Oncology · 2021 · 139 citations
Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations
European Urology · 2019 · 133 citations
Germline and Somatic Mutations in Prostate Cancer for the Clinician
Review · Journal of the National Comprehensive Cancer Network · 2019 · 111 citations

Heather Cheng
23 papers
Michael Schweizer
11 papers
Evan Yu
9 papers
Rana McKay
9 papers · 5 as a resident
Robert Montgomery
8 papers
Andrew Armstrong
7 papers
Emmanuel Antonarakis
7 papers
Alan Bryce
6 papers
CM
Catherine Marshall
6 papers
Oliver Sartor
6 papers
Peter Nelson
6 papers
AA
Ajjai Alva
5 papers

Clinical trials

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy
Principal investigator · Completed · Phase 2
OHSU Knight Cancer Institute
2014–2024
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Study chair · Recruiting · Phase 3
Canadian Cancer Trials Group
2025–2031
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Site PI · Recruiting · Phase 2
Alliance for Clinical Trials in Oncology
2025–2034
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2024–2031